| TAH Drug Code | ELIDP |
|---|---|
| Indications | Relief of post-herpetic neuralgia. |
| Dosing | Apply to intact skin once daily up to 12 hours within a 24-hours period. Maximum: 3 patches/24 hours. When needed, the patches may be cut into smaller sizes with scissors prior to removal of the release liner. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | Known history of sensitivity to local anesth of the amide type. Avoid in cardiac disease patients: 2nd & 3rd degree AV block (without pacemaker), severe SA block (without pacemaker), current administration of Class I antiarrhythmic agents (quinidine, flecainide, disopyramide, procainamide) to patients previously on amiodarone therapy, hypotension due to arrhythmia, bradycardia, ventricular arrhythmia. |
| Adverse Effects | Severe hepatic disease. Avoid application to broken or inflamed skin or contact with eyes. |
| Pregnancy | Compatible |
| Lactation | No (Limited) Human Data - Probably Compatible |
| More Info | UpToDate |
| TAH Drug Code | EXYLJ |
|---|---|
| Indications | Surface anaesth. |
| Dosing | Urethral anesthesia Men 20 mL is instilled slowly until the patient has a feeling of tension or until almost half the tube (10 mL) has been emptied. Apply a penile clamp for several mins, then instill the rest of the jelly. Women 5-10 mL in small portions to fill the whole urethra. Endoscopy 10-20 mL. Lubrication for endotracheal intubation 2 mL applied to the surface of the tube just prior to insertion. Children < 12 years Maximum: 6 mg/kg. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | Known hypersensitivity to local anesth of the amide type. |
| Adverse Effects | Rarely, anaphylactic shock. Post-op sore throat following endotracheal tube lubrication. Acute systemic toxicity. |
| Pregnancy | Compatible |
| Lactation | No (Limited) Human Data - Probably Compatible |
| More Info | UpToDate |
| TAH Drug Code | EXYSP |
|---|---|
| Indications | Local anesthesia. |
| Dosing | Each press of the plunger releases 10mg of Lidocaine. No need to dry the sprayed area before use. For mucosal surface anesthesia, effect lasts 10-15 minutes. Anesthesia occurs within 1-5 minutes, depending on the area of use. - ENT procedures: 3 sprays for maxillary sinus puncture or minor surgery. - Pleural fluid drainage: 3 sprays. - Labor and delivery: Up to 20 sprays (200mg Lidocaine) at most. - Respiratory or digestive procedures: Up to 20 sprays (200mg Lidocaine), with a maximum of 400mg Lidocaine for prolonged procedures. Total dosage should not exceed 400mg when combined with other Lidocaine products. - Dental procedures: 1-5 mucosal sprays. Special Patients: Elderly, children above 12 years, acutely ill, or septic patients should receive appropriate doses based on their age, weight, and condition. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | Allergic history to local anesthetics of the amide class or other ingredients in the spray solution. |
| Adverse Effects | Local irritation, allergic reactions, acute systemic toxicity. |
| Pregnancy | Compatible |
| Lactation | No (Limited) Human Data - Probably Compatible |
| More Info | UpToDate |
| TAH Drug Code | IXYL2 |
|---|---|
| Indications | For the production of local or regional anesth by infiltration, IV regional anesth, minor & major nerve blocks, epidural block & subarachnoid block. |
| Dosing | Maximum recommended single dose of lidocaine is 3 mg/kg (plain solution) or 7 mg/kg (solution with adrenaline). Adult, 70 kg: Retrobulbar or peribulbar: 4 mL of 2% solution (80 mg). Sciatic nerve block: 15-20 mL of 2% solution (300-400 mg). Epidural anesthesia, Lumbar: 15-25 mL of 2% solution (300-500 mg). Epidural anesthesia, Thoracic: 15-20 mL of 2% solution (300-400 mg). |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | Epidural or spinal anesth in patients with uncorrected hypotension or with coagulation disorders or receiving anti-coagulation treatment; inflammation &/or sepsis in the region of proposed inj or in the presence of septicemia; general contraindications related to epidural anesth should also be taken into account. |
| Adverse Effects | CNS reactions, either excitatory or depressant. CV reactions, mainly depressant. Maternal hypotension. Rarely allergic reactions. |
| Pregnancy | Compatible |
| Lactation | No (Limited) Human Data - Probably Compatible |
| More Info | UpToDate |
| TAH Drug Code | IXYL2V |
|---|---|
| Indications | Emergency treatment of ventricular arrhythmia. |
| Dosing | Adult IV 50-100 mg (1-2 mg/kg) slow IV within 1-2 mins. If no effect is observed after the 1st inj, the same dose may be repeated after 5 mins. May repeat at 10-20 min intervals but not > 300 mg during a 1 hr period. IV infusion 1-2 mg/min. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | Complete AV block. Amide local anesthetic hypersensitivity. |
| Adverse Effects | Conduction block, shock. Rarely malignant hyperthermia. Confusion, dizziness, drowsiness, nervousness, euphoria, vomiting, numbness. |
| Pregnancy | Compatible |
| Lactation | No (Limited) Human Data - Probably Compatible |
| More Info | UpToDate |